Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics



beta thalassemia chromosome 11 :: Article Creator

Vitamins By Condition

Considering taking supplements to treat beta thalassemia?

Below is a list of common natural remedies used to treat or reduce the symptoms of beta thalassemia. Follow the links to read common uses, side effects, dosage details and user reviews for the vitamins and supplements listed below.

Treatment

Effectiveness

Reviews

Learn about User Reviews and read IMPORTANT information about user generated content

Conditions of Use and Important Information: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.

© Therapeutic Research Faculty 2018.


What To Include And Avoid In A Thalassemia Minor Diet

Individuals with thalassemia minor may need to limit the amount of iron in their diet. Healthcare professionals typically recommend a nutritious diet rich in fruits and vegetables and low in fats for people with the condition.

Thalassemia is a genetic condition in which a person's body does not produce enough hemoglobin. This is an important protein present in red blood cells. These cells do not function as well as they should with low levels of hemoglobin, so they cannot carry oxygen to other cells in a person's body. All cells need oxygen to function.

Due to this lack of oxygen in the cells, people with thalassemia can develop anemia, which may cause them to feel tired and weak.

Thalassemia minor is a relatively mild form of the disease that may not present with any symptoms. Although doctors may not need to treat some people with thalassemia minor, maintaining a nutritious diet can help manage the condition.

This article explores which foods to eat and avoid in a thalassemia minor diet. It also discusses tips for managing the condition and how doctors treat it.

The Centers for Disease Control and Prevention (CDC) advises that people with thalassemia eat a diet high in fruits and vegetables. They also highlight that a person's diet should be lower in fats.

Additionally, research into thalassemia major in a 2023 review found that vitamin C helps the body excrete iron from the gut. However, consuming large quantities of vitamin C without using an iron chelator, such as deferoxamine, can pose a risk of fatal arrhythmias.

Furthermore, vitamin C helps to support the immune system. The CDC explains that people with thalassemia are immunocompromised, meaning some of their body's defenses against infection do not function properly.

Therefore, including vitamin C in a thalassemia minor diet, with a healthcare professional's guidance, may be beneficial.

However, they may not be necessary for everyone. Individuals with thalassemia minor can discuss whether they need to monitor their vitamin C intake with a doctor, particularly if they are receiving blood transfusions.

Fruits and vegetables that are suitable sources of vitamin C include:

Research indicates that hepcidin can undergo suppression in people with thalassemia, resulting in higher iron levels in the body. Hepcidin is a hormone that regulates the breakdown of iron in the body,

In people with thalassemia who need blood transfusions, iron can build and deposit in certain organs in the body, such as the liver and spleen. Therefore, people receiving frequent blood transfusions may have a higher risk of higher iron levels.

However, blood transfusions are usually only necessary for more severe forms of thalassemia. Occasionally, those with mild types may require a transfusion to manage complications of the condition or following surgery or childbirth.

Due to these considerations, the CDC advises that people with thalassemia may need to limit foods high in iron. However, individuals with thalassemia minor should discuss this with their doctor.

The CDC notes that foods containing higher amounts of iron include:

  • fish
  • meat
  • products fortified with iron, such as some cereals and orange juices
  • some vegetables, such as spinach
  • According to a 2023 review, thalassemia minor usually causes no symptoms and does not increase the risk of further illness or death.

    However, someone with thalassemia can help manage their condition by:

  • eating a nutritious diet
  • avoiding excess iron intake
  • exercising regularly
  • building relationships with others
  • taking a folic acid supplement, if a doctor advises
  • taking precautions against infections, such as keeping vaccinations up-to-date
  • According to the CDC, the type of treatment doctors provide depends on how severe the thalassemia is. They explain that the more severe the disease is, the less hemoglobin there is in a person's body, meaning their anemia may be worse.

    Doctors may treat anemia in thalassemia using blood transfusions. Some people with thalassemia major may need regular blood transfusions. However, the CDC states that those with thalassemia minor do not typically need transfusions because they may not have anemia or only have a mild case.

    In addition, the CDC explains that doctors often prescribe folic acid to those with thalassemia to help red blood cells develop.

    Someone with thalassemia minor may have mild symptoms or none at all. Therefore, they may only require little, if any, treatment from a doctor.

    Thalassemia minor is a milder form of the genetic condition thalassemia. People with thalassemia minor may not experience any symptoms or require any treatment for the condition.

    Because of how the body processes iron in the gut, people with thalassemia may have higher levels of the metal in their bodies. Additionally, if someone with the condition requires a blood transfusion, they may develop excess amounts of iron, which could be dangerous.

    Experts advise people with thalassemia to monitor their iron intake and limit iron-rich foods, such as meat and fish. Eating a varied diet, including plenty of vegetables and fruit and lower amounts of fat, can help someone with thalassemia minor manage their condition.

    However, individuals with thalassemia minor need to speak with a healthcare professional before changing their diet. A doctor can also recommend other methods to manage the condition.


    Morning Rounds: For Kids With High BMI, Task Force Not Ready To Recommend Weight Loss Drugs

    Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

    Good morning. Don't miss Brittany Trang's compelling story about seven-year-old Shelby Campbell's life — and her family's — while being treated for beta thalassemia with gene therapy.

    What 'one time' means when you're 7 years old and gene therapy takes a grueling year Shelby and her parents sit together for family pancake breakfast on Saturday morning at home in Mechanicsburg, PA on August 26, 2023. Amanda Berg for STAT

    Two gene therapies approved by the FDA last week have been heralded as one-time, essentially curative therapies. But what does that mean? To leave behind beta thalassemia or sickle cell disease, "one time" means months, or for seven-year-old Shelby Campbell, more than one year. That includes seven weeks in the hospital, toxic chemotherapy to wipe out defective cells, hair loss, high fevers and mouth sores, and isolation from friends and school.

    STAT's Brittany Trang chronicled the Campbell family's journey through Shelby's treatment for beta thalassemia with Bluebird Bio's Zynteglo. "It's definitely not a quick fix or an easy fix," said her mother, Michelle Campbell. Yet by the end, Shelby was giving advice to another child about feeding-tube insertion: "You might need to get it in a few times but once you get used to it, it's not that scary and you know what to expect." Read more.

    Humana sued again over algorithm used to deny care

    A second class action lawsuit from Medicare Advantage beneficiaries was filed yesterday against Humana, also alleging that the health insurance giant used an algorithm to cut off payment for rehabilitative care needed by patients recovering from serious illnesses and injuries. This one, filed in U.S. District Court in Western Kentucky, argues Humana's reliance on the algorithm was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people. An earlier complaint was filed in November against the algorithm's maker, NaviHealth, and its owner, UnitedHealth Group.

    Both suits follow a STAT investigation that found Medicare Advantage insurers nationwide are using the algorithm to cut off patients' rehab care. Complaints alleging the improper denial of care are common, STAT's Bob Herman and Casey Ross point out, but these cases are among the first to challenge insurers' reliance on an internal algorithm. Read more.

    Promising news about an under-the-radar sickle cell treatment

    Historic approvals of two pricey ($2.2 million and $3.1 million) gene therapies for sickle cell disease have grabbed our attention, but there's a less expensive, more traditional approach turning heads at the American Society of Hematology in San Diego. Yesterday scientists reported advances in bone marrow transplantation, a decades-old approach that means patients need a well-matched donor and a hefty dose of chemotherapy, two requirements hard for most patients to meet.

    In the new mid-stage trial, after sickle cell patients were given a gentler course of chemo and an infusion of half-matched cells, they had less pain, 95% were alive two years after transplant, and only 7% experienced a severe immune reaction, study co-author Adetola Kassim told reporters. "Whatever we do in terms of novel research, if it cannot reach the patients who need it, what's the whole idea?" study co-author Adetola Kassim said. STAT's Jonathan Wosen has more. And STAT's Jason Mast reports on about early animal data from Novartis presented at the same meeting about a potential pill for the disease.

    Doctors call out ableism in cancer care, where assumption can harm patients Spaulding Rehabilitation Network Spaulding Rehabilitation Network

    People who have a disability often need to educate others about what they can and can't do, including doctors whose assumptions can undermine their care. In cancer, for example, clinicians might assume a woman who uses a wheelchair isn't sexually active, so doesn't need to be tested for the virus that causes cervical cancer. After a cancer diagnosis, treatment can follow outdated decision trees that depend on a patient's ability to walk as a benchmark for tolerating chemotherapy.

    "To make an assumption that a wheelchair user must inherently be someone with a significant burden of chronic disease is a very ableist assumption," Cheri Blauwet, chief medical officer at Spaulding Rehabilitation Hospital (pictured above with David Estrada), told me. It's perhaps an understatement to say she knows whereof she speaks. She's a Paralympic gold medalist and two-time winner of both the Boston Marathon and the New York City Marathon in wheelchair racing. I have more here.

    For kids with high BMI, task force not ready to recommend weight loss drugs

    In its new draft recommendation on high BMI in children and adolescents, the U.S. Preventive Services Task Force has moved from its 2017 guidance suggesting screening to urging intensive, comprehensive behavioral interventions. Today's recommendations, open for comment until Jan. 16, stop short of weight-loss medications for the roughly 20% of children and teens with high BMI in the U.S., saying "more research is needed to fully understand the long-term health outcomes for medications."

    Instead, the group recommends providing or referring kids age 6 and older who have a BMI above the 95th percentile for age and sex on the growth chart to behavioral interventions such as supervised exercise, counseling for behavior change, and information about healthy eating. The American Academy of Pediatrics has come out in favor of weight-loss drugs for adolescents, but as this New York Times story tells us, many pediatricians are reluctant to prescribe them.

    Experimental male birth-control pill enters trial

    We haven't heard too much lately about male birth control, but a San Francisco startup hopes to change that story with a non-hormonal drug candidate that began its Phase 1 clinical trial today in the U.K. To test the safety, tolerability, and functioning of the oral drug in 16 participants. YourChoice Therapeutics is betting on century-old science that discovered mice, rats, and monkeys with vitamin A deficiency were infertile, which dozens of papers have since confirmed. The experimental drug is designed to stop the metabolism of vitamin A in the testicles, thus blocking both the production and the release of sperm — completely eliminating the chances of fertilizing an egg.

    Ultimately, the team behind YCT-529 hopes that if their product is successful, it might help change the dynamics of contraception, and make it more of a shared responsibility. STAT's Annalisa Merelli has more, including another male contraceptive product currently being studied.

    What we're reading
  • Pharmacies share medical data with police without a warrant, inquiry finds, Washington Post

  • CPR can be lifesaving for some, futile for others. Here's what makes the difference, NPR
  • A targeted therapy shows it can offer a 'last, great chance' for some acute leukemia patients, STAT
  • Thousands of patients may be undergoing vascular procedures too soon or unnecessarily, ProPublica
  • Maze CEO 'personally disappointed' in Sanofi decision to terminate partnership, STAT





  • Comments